key: cord-1042784-7kxkxgg8 authors: Barnett, William R.; Radhakrishnan, Muthukumar; Macko, John; Hinch, Bryan T.; Altorok, Nezam; Assaly, Ragheb title: Initial MEWS score to predict ICU admission or transfer of hospitalized patients with COVID-19: a retrospective study date: 2020-09-02 journal: J Infect DOI: 10.1016/j.jinf.2020.08.047 sha: f45bfaff1d9a60796d7d17960d6c81ade5795f39 doc_id: 1042784 cord_uid: 7kxkxgg8 nan Early warning scores (EWS) were introduced in early 2001 to identify patients at risk of deterioration in a busy clinical environment as a track-and-trigger system where an increasing score produced an escalated response. 1 EWS have demonstrated better capability in identifying deteriorating patients leading to improved clinical outcome. 2 Furthermore, an EWS at admission can be used to determine in-hospital mortality and intensive care unit (ICU) transfer. [2] [3] [4] Our academic medical center developed a MEWS scoring system in 2015 and was rolled out hospital-wide the following year. Since serious adverse events in hospitalized patients are often preceded by signs of clinical deterioration, we believed MEWS scores could be used to predict events, such as cardiopulmonary arrest. As the coronavirus pandemic continues, could a modified early warning score (MEWS) provide any usefulness in predicting ICU level care among hospitalized COVID-19 patients? A retrospective study was conducted at the University of Toledo Medical Center (Toledo, OH) on COVID-19 positive patients hospitalized from late March to the end of May 2020. All patients were confirmed for COVID-19 by real-time reverse transcription polymerase chain reaction. Patient demographics, biometrics, and comorbidities were gathered from the electronic medical record. The highest level of hospital disposition was used to create the medical floor and ICU groups. The MEWS scores, which are calculated hourly using the criteria in Figure 1 , were retrieved from an electronic database. Initial MEWS scores were considered either at admission or prior to ICU transfer. Sequential organ failure assessment (SOFA) scores were manually calculated and included as a point of comparison. 5 As a validated scoring system, SOFA scores are used to determine a patient's prognosis and has been considered for use in hospitalized COVID-19 patients. 6 Overall, 142 COVID-19 positive patients were identified in the hospital during the study period. The baseline characteristics of each group are represented in Table 1 The study suggests that MEWS could be used as a surrogate measure alongside other parameters to determine ICU admission or transfer when the SOFA score is unavailable. A downside to using the SOFA score at admission is the requirement for lab values, such arterial blood gas, creatinine, platelets, and bilirubin for score accuracy. Most of the time these values are absent early in a patient's hospital course. Among COVID-19 patients, MEWS may have another slight advantage over SOFA considering the latter does not take into consideration temperature, respiratory rate, oxygen therapy, and oxygen saturation. We questioned whether these nuances in the MEWS scoring system would be able to detect COVID-19 patients at risk for clinical deterioration especially in the context of 'silent hypoxia' 7 . For example, based on the available information as presented in Tobin et al., these patients would have quite low SOFA scores. Even quick SOFA scoring would not sufficiently capture silent hypoxia considering most patients do not present with altered mental status or tachypnea. 8 In comparison, their MEWS scores would extend well beyond our threshold of 5 considering fever is a prominent feature of COVID-19, use of supplemental oxygen, and oxygen saturation below 90%. There are several limitations to these study findings, which should be addressed. First, the study suffers from a small sample size from a single institution and should be replicated with a larger cohort of patients. Secondly, the scoring systems mentioned in this study have been developed for different reasons other than predicting hospital disposition. Thirdly, we did not explore other options, such as scoring trends or using the highest score in the preceding 24-hour period in our prediction model. Considering MEWS is a less burdensome scoring system, hospitals should consider adopting a method to calculate MEWS scores on admission with a plan to periodically monitor their patients for increasing scores. Additionally, an optimal cutoff value can aid in decisions to either admit or transfer patients with known or suspected COVID-19 to higher levels of care. Availability of data and materials The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. The authors declare that they have no competing interests. No funding received for preparing this manuscript. Author's contributions WB conceived and designed the study. MR and JM participated in the acquisition of data. WB analyzed the data. WB drafted the manuscript, and WB, NA, BH, and RA revised the manuscript. All authors read and approved the final manuscript. WB is guarantor of this work and had full access to all the data in the study and takes responsibility for its integrity and the accuracy of the data analysis. Validation of a modified Early Warning Score in medical admissions Are Early Warning Scores Useful Predictors for Mortality and Morbidity in Hospitalised Acutely Unwell Older Patients? A Systematic Review In-hospital mortality and morbidity of elderly medical patients can be predicted at admission by the Modified Early Warning Score: a prospective study An Early Warning Score to predict ICU admission in COVID-19 positive patients Serial Evaluation of the SOFA Score to Predict Outcome in Critically Ill Patients Admission decisions to intensive care units in the context of the major COVID-19 outbreak: local guidance from the COVID-19 Paris-region area Why COVID-19 Silent Hypoxemia Is Baffling to Physicians Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) None.